🔎 Trials Near Me

ホーム › 肥満症 › インディアナ州 › Indianapolis

Indianapolis、INにおける肥満症の臨床試験

Indianapolisとその周辺地域(約30マイル以内)の拠点で、肥満症に関する20件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

被験者募集中第2相
  • Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

被験者募集中第3相
  • IU Health - Riley Physicians Endo-Diab, Indianapolis
8歳〜18歳 · 全性別 · 2026/09/30更新 · NCT07253285

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

被験者募集中第3相
  • Midwest Inst For Clin Res, Indianapolis
18歳以上 · 全性別 · 2026/09/28更新 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

被験者募集中第3相
  • Midwest Inst For Clin Res, Indianapolis
18歳以上 · 全性別 · 2026/09/28更新 · NCT07668414

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

被験者募集中第3相
  • Indiana University Health University Hospital, Indianapolis
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

被験者募集中第3相
  • Riley Hospital for Children, Indianapolis
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

被験者募集中第3相
  • Indiana University Health University Hospital, Indianapolis
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

被験者募集中第3相
  • Midwest Inst For Clin Res, Indianapolis
18歳以上 · 全性別 · 2026/09/24更新 · NCT07339423

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

被験者募集中第3相
  • DM Clinical Research - Indianapolis, Indianapolis
18歳以上 · 全性別 · 2026/09/22更新 · NCT07282600

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

被験者募集中第3相
  • AURORA-1 Clinical Site, Indianapolis
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

被験者募集中第3相
  • AURORA-2 Clinical Site, Indianapolis
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

被験者募集中第3相
  • Ascension Medical Group, Indianapolis
18歳〜99歳 · 全性別 · 2026/09/16更新 · NCT07037459

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

被験者募集中第2相
  • Investigators Research Group, Brownsburg · 14マイル先
18歳〜75歳 · 全性別 · 2026/09/14更新 · NCT06897475

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

被験者募集中第4相
  • Dawes Fretzin Clinical Research Group, LLC, Indianapolis
  • The Indiana Clinical Trials Center, PC, Plainfield · 14マイル先
18歳以上 · 全性別 · 2026/09/04更新 · NCT06857942

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

被験者募集中第3相
  • Midwest Inst For Clin Res, Indianapolis
18歳以上 · 全性別 · 2026/09/04更新 · NCT07745504

The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action

被験者募集中第2相
  • Indiana University School of Medicine, Indianapolis
11歳〜18歳 · 全性別 · 2026/08/21更新 · NCT05414409

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

被験者募集中第3相
  • Indiana University Health Methodist Hospital, Indianapolis
18歳以上 · 全性別 · 2026/08/18更新 · NCT07567001

A Sensory Strategy to Cut Sugary Beverages in African/American and Latine Adolescents

被験者募集中健康なボランティア歓迎
  • Indiana University Hospital, Indianapolis
12歳〜18歳 · 全性別 · 2026/08/06更新 · NCT07223151

Fibrosis Lessens After Metabolic Surgery

被験者募集中第4相健康なボランティア歓迎
  • Indiana University, Indianapolis
18歳〜75歳 · 全性別 · 2026/07/31更新 · NCT06374875

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

被験者募集中
  • Indiana University, Indianapolis
18歳〜45歳 · 女性 · 2026/06/24更新 · NCT05124808

他の都市における肥満症の試験

Indianapolisにおける他の研究

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。